Postdoctoral Fellow Weixin LIU - CUHK Research Portal - CONVERIS Research Information System

Go to Header Go to Navigation Go to Content Go to Footer

Dr. LIU Weixin

Personal Information

Position and Department

Postdoctoral Fellow, Department of Medicine and Therapeutics

CUHK Research Outputs

Blood microbial signatures associated with mortality in patients with sepsis: A pilot study (2024)

Defining the biogeographical map and potential bacterial translocation of microbiome in human 'surface organs' (2024)

Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase (2024)

Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma (2023)

Carnobacterium maltaromaticum boosts intestinal vitamin D production to suppress colorectal cancer in female mice (2023)

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis (2023)

METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy (2023)

Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites (2022)

DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance (2022)

Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis (2022)

MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target (2022)